Ou L - Search Results

1

Clinical characteristics, treatment strategies and oncologic outcomes of primary retroperitoneal tumours: a retrospective analysis in the Chinese population.

Xu J, Cheng R, Ou L, Wei Z, Wang Y, Cui L, Shi B. Xu J, et al. Among authors: ou l. Ann R Coll Surg Engl. 2021 Oct;103(9):645-650. doi: 10.1308/rcsann.2021.0003. Epub 2021 Aug 26. Ann R Coll Surg Engl. 2021. PMID: 34435514 Free PMC article.

2

Resilience and quality of life among Wenchuan earthquake survivors: the mediating role of social support.

Xu J, Ou L. Xu J, et al. Among authors: ou l. Public Health. 2014 May;128(5):430-7. doi: 10.1016/j.puhe.2014.03.002. Epub 2014 May 2. Public Health. 2014. PMID: 24792190

3

FAM64A is an androgen receptor-regulated feedback tumor promoter in prostate cancer.

Zhou Y, Ou L, Xu J, Yuan H, Luo J, Shi B, Li X, Yang S, Wang Y. Zhou Y, et al. Among authors: ou l. Cell Death Dis. 2021 Jul 2;12(7):668. doi: 10.1038/s41419-021-03933-z. Cell Death Dis. 2021. PMID: 34215720 Free PMC article.

4

Role of hypermethylated-lncRNAs in the prognosis of bladder cancer patients.

Luo J, Xu J, Ou L, Zhou Y, Yun H, Yang Y, Wu X, Wang Y. Luo J, et al. Among authors: ou l. J Int Med Res. 2021 Oct;49(10):3000605211049946. doi: 10.1177/03000605211049946. J Int Med Res. 2021. PMID: 34617815 Free PMC article.

5

Urachal tuberculosis with invasion of the bladder wall: A case report and literature review.

Ou L, Luo J, Wei Z, Zheng A, Xu J, Shi B. Ou L, et al. Actas Urol Esp (Engl Ed). 2022 Jan-Feb;46(1):1-3. doi: 10.1016/j.acuroe.2020.12.007. Epub 2021 Nov 24. Actas Urol Esp (Engl Ed). 2022. PMID: 34838494 Review. English, Spanish. No abstract available.

6

FAM107A as a Tumor Suppressor in Bladder Cancer Inhibits Cell Proliferation, Migration, and Invasion.

Ou L, Wei Z, Xu J, Li W, Zhou Y, Wang Y, Shi B. Ou L, et al. Ann Clin Lab Sci. 2022 Mar;52(2):260-268. Ann Clin Lab Sci. 2022. PMID: 35414505

7

SMARCC1 Enters the Nucleus via KPNA2 and Plays an Oncogenic Role in Bladder Cancer.

Wei Z, Xu J, Li W, Ou L, Zhou Y, Wang Y, Shi B. Wei Z, et al. Among authors: ou l. Front Mol Biosci. 2022 May 20;9:902220. doi: 10.3389/fmolb.2022.902220. eCollection 2022. Front Mol Biosci. 2022. PMID: 35669562 Free PMC article.

8

ITM2A inhibits the progression of bladder cancer by downregulating the phosphorylation of STAT3.

Jiang J, Xu J, Ou L, Yin C, Wang Y, Shi B. Jiang J, et al. Among authors: ou l. Am J Cancer Res. 2024 May 15;14(5):2202-2215. doi: 10.62347/KHCC9690. eCollection 2024. Am J Cancer Res. 2024. PMID: 38859860 Free PMC article.

9

Prognostic Value of Lymphocyte-to-Monocyte Ratio (LMR) in Patients With Prostate Cancer: A Systematic Review and Meta-Analysis.

Xiang Q, Liu Y, Xiao J, Ou L, Du J. Xiang Q, et al. Among authors: ou l. Am J Mens Health. 2024 Mar-Apr;18(2):15579883241234747. doi: 10.1177/15579883241234747. Am J Mens Health. 2024. PMID: 38514969 Free PMC article. Review.

10

Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics.

Ou L, Setegne MT, Elliot J, Shen F, Dassama LMK. Ou L, et al. Chem Rev. 2025 Jan 17. doi: 10.1021/acs.chemrev.4c00595. Online ahead of print. Chem Rev. 2025. PMID: 39818743 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,024 results

Search Page

Filters